非酒精性脂肪肝患者早期肾损伤:一项横断面研究

T. Lei, Liangping Li
{"title":"非酒精性脂肪肝患者早期肾损伤:一项横断面研究","authors":"T. Lei, Liangping Li","doi":"10.3760/CMA.J.ISSN.0254-1432.2019.05.010","DOIUrl":null,"url":null,"abstract":"Objective \nTo investigate early kidney injury in the patients with non-alcoholic fatty liver disease (NAFLD) without hypertension, diabetes and history of kidney diseases, as so to provide evidence for preventing early kidney injury in patients with NAFLD. \n \n \nMethods \nFrom December 2014 to January 2016, 169 subjects visiting Sichuan Provincial People′s Hospital were recruited. Among them, 104 cases were in NAFLD group, 31 cases were in simple obesity group (overweight or obesity), and 34 subjects were in the healthy control group. The general data, biochemical indexes, metabolic indexes, biochemical indexes of kidney, and early kidney injury makers, including serum β2-microglobulin, urinary albumin and creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR), were detected. Least significant difference-t test, chi-square test and Spearman correlation analysis were performed for statistical analysis. \n \n \nResults \nCompared with simple obesity group, alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyl transpeptadase (GGT), fasting insulin level, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, ACR and β2 microglobulin were higher in NAFLD group ((21.13±8.14) U/L vs. (66.20±44.34) U/L, (24.80±9.57) U/L vs. (49.78±25.41) U/L, (19.26±7.88) U/L vs. (66.53±56.34) U/L, (7.03±1.52) mU/L vs. (9.55±5.41) mU/L, 1.22±0.38 vs. 2.23±2.01, (62.90±10.01) μmol/L vs. (71.75±10.80) μmol/L, (4.41±1.16) μg/mg vs. (13.76±9.56) μg/mg, (1.46±0.26) mg/L vs. (2.01±0.53) mg/L); however the eGFR was lower (112.46±11.90) mL·min-1·(1.73 m2)-1 vs. (101.09±17.17) mL·min-1·(1.73 m2)-1). The differences were statistically significant (t=9.825, 8.250, 8.288, 4.229, 4.121, 4.007, 9.732, 7.792 and -3.443, all P 0.05). Compared with healthy control group, the renal injury indexes serum creatinine, ACR and β2 microglobulin of NAFLD group were higher((58.78±7.77) μmol/L vs. (71.75±10.80) μmol/L, (1.01±0.32) μg/mg vs. (13.76±9.56) μg/mg, (1.12±0.15) mg/L vs. (2.01±0.53) mg/L), and the eGFR was lower ((115.10±12.59) mL·min-1·(1.73 m2)-1 vs. (101.09±17.17) mL·min-1·(1.73 m2)-1). The differences were statistically significant (t=7.621, 13.591, 15.126 and -5.120, all P<0.01). Compared with healthy control group, the renal injury indexes ACR and β2 microglobulin of simple obesity group were higher ((1.01±0.32) μg/mg vs. (4.41±1.16) μg/mg, (1.12±0.15) mg/L vs. (1.46±0.26) mg/L), and the differences were statistically significant (t=9.732 and 7.792, both P<0.01). ACR of NAFLD patients was positively correlated with body mass index, waist circumference, triglyceride level, total cholesterol level, low density lipoprotein level, fasting blood glucose level, two-hour postprandial blood glucose, fasting insulin level and HOMA-IR (r=0.554, 0.327, 0.314, 0.353, 0.176, 0.195, 0.552, 0.364 and 0.987, all P<0.05), and was negatively correlated with high density lipoprotein (r=-0.330, P<0.01). \n \n \nConclusions \nNAFLD is closely related with chronic kidney disease at same baseline of gender, age, blood glucose, blood lipids, and blood pressure. Abnormal metabolism of glycolipids, obesity and insulin resistance may be the mechanisms of early kidney injury in NAFLD patients. Combination of ACR and β2 microglobulin are more sensitive than serum creatinine and eGFR in detecting early renal injury in NAFLD patients. \n \n \nKey words: \nNonalcoholic fatty liver disease; Obesity; Chronic kidney disease; Early kidney injury","PeriodicalId":10009,"journal":{"name":"中华消化杂志","volume":"25 1","pages":"322-326"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Early kidney injury in patients with non-alcoholic fatty liver disease: a cross-sectional study\",\"authors\":\"T. Lei, Liangping Li\",\"doi\":\"10.3760/CMA.J.ISSN.0254-1432.2019.05.010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo investigate early kidney injury in the patients with non-alcoholic fatty liver disease (NAFLD) without hypertension, diabetes and history of kidney diseases, as so to provide evidence for preventing early kidney injury in patients with NAFLD. \\n \\n \\nMethods \\nFrom December 2014 to January 2016, 169 subjects visiting Sichuan Provincial People′s Hospital were recruited. Among them, 104 cases were in NAFLD group, 31 cases were in simple obesity group (overweight or obesity), and 34 subjects were in the healthy control group. The general data, biochemical indexes, metabolic indexes, biochemical indexes of kidney, and early kidney injury makers, including serum β2-microglobulin, urinary albumin and creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR), were detected. Least significant difference-t test, chi-square test and Spearman correlation analysis were performed for statistical analysis. \\n \\n \\nResults \\nCompared with simple obesity group, alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyl transpeptadase (GGT), fasting insulin level, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, ACR and β2 microglobulin were higher in NAFLD group ((21.13±8.14) U/L vs. (66.20±44.34) U/L, (24.80±9.57) U/L vs. (49.78±25.41) U/L, (19.26±7.88) U/L vs. (66.53±56.34) U/L, (7.03±1.52) mU/L vs. (9.55±5.41) mU/L, 1.22±0.38 vs. 2.23±2.01, (62.90±10.01) μmol/L vs. (71.75±10.80) μmol/L, (4.41±1.16) μg/mg vs. (13.76±9.56) μg/mg, (1.46±0.26) mg/L vs. (2.01±0.53) mg/L); however the eGFR was lower (112.46±11.90) mL·min-1·(1.73 m2)-1 vs. (101.09±17.17) mL·min-1·(1.73 m2)-1). The differences were statistically significant (t=9.825, 8.250, 8.288, 4.229, 4.121, 4.007, 9.732, 7.792 and -3.443, all P 0.05). Compared with healthy control group, the renal injury indexes serum creatinine, ACR and β2 microglobulin of NAFLD group were higher((58.78±7.77) μmol/L vs. (71.75±10.80) μmol/L, (1.01±0.32) μg/mg vs. (13.76±9.56) μg/mg, (1.12±0.15) mg/L vs. (2.01±0.53) mg/L), and the eGFR was lower ((115.10±12.59) mL·min-1·(1.73 m2)-1 vs. (101.09±17.17) mL·min-1·(1.73 m2)-1). The differences were statistically significant (t=7.621, 13.591, 15.126 and -5.120, all P<0.01). Compared with healthy control group, the renal injury indexes ACR and β2 microglobulin of simple obesity group were higher ((1.01±0.32) μg/mg vs. (4.41±1.16) μg/mg, (1.12±0.15) mg/L vs. (1.46±0.26) mg/L), and the differences were statistically significant (t=9.732 and 7.792, both P<0.01). ACR of NAFLD patients was positively correlated with body mass index, waist circumference, triglyceride level, total cholesterol level, low density lipoprotein level, fasting blood glucose level, two-hour postprandial blood glucose, fasting insulin level and HOMA-IR (r=0.554, 0.327, 0.314, 0.353, 0.176, 0.195, 0.552, 0.364 and 0.987, all P<0.05), and was negatively correlated with high density lipoprotein (r=-0.330, P<0.01). \\n \\n \\nConclusions \\nNAFLD is closely related with chronic kidney disease at same baseline of gender, age, blood glucose, blood lipids, and blood pressure. Abnormal metabolism of glycolipids, obesity and insulin resistance may be the mechanisms of early kidney injury in NAFLD patients. Combination of ACR and β2 microglobulin are more sensitive than serum creatinine and eGFR in detecting early renal injury in NAFLD patients. \\n \\n \\nKey words: \\nNonalcoholic fatty liver disease; Obesity; Chronic kidney disease; Early kidney injury\",\"PeriodicalId\":10009,\"journal\":{\"name\":\"中华消化杂志\",\"volume\":\"25 1\",\"pages\":\"322-326\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-05-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中华消化杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.05.010\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华消化杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.0254-1432.2019.05.010","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的探讨无高血压、糖尿病、无肾脏病史的非酒精性脂肪性肝病(NAFLD)患者早期肾损伤情况,为预防NAFLD患者早期肾损伤提供依据。方法选取2014年12月至2016年1月在四川省人民医院就诊的患者169例。其中,NAFLD组104例,单纯性肥胖组(超重或肥胖)31例,健康对照组34例。检测一般资料、生化指标、代谢指标、肾脏生化指标及早期肾损伤标志物,包括血清β2-微球蛋白、尿白蛋白与肌酐比值(ACR)和肾小球滤过率(eGFR)。采用t检验、卡方检验和Spearman相关分析进行统计学分析。结果与单纯性肥胖组比较,NAFLD组丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)、γ-谷氨酰转肽酶(GGT)、空腹胰岛素水平、稳态模型评估-胰岛素抵抗(HOMA-IR)、血清肌酐、ACR、β2微球蛋白升高((21.13±8.14)U/L vs(66.20±44.34)U/L、(24.80±9.57)U/L vs(49.78±25.41)U/L、(19.26±7.88)U/L vs(66.53±56.34)U/L、(7.03±1.52)mU/L vs(9.55±5.41)mU/L、(1.22±0.38)vs(2.23±2.01)、(62.90±10.01)μmol / L和(71.75±10.80)μmol / L(4.41±1.16)μg / mg和μg /毫克(13.76±9.56),(1.46±0.26)mg / L和(2.01±0.53)mg / L);eGFR(112.46±11.90)mL·min-1·(1.73 m2)-1低于(101.09±17.17)mL·min-1·(1.73 m2)-1)。差异有统计学意义(t=9.825、8.250、8.288、4.229、4.121、4.007、9.732、7.792、-3.443,P均为0.05)。与健康对照组相比,NAFLD组肾损伤指标血清肌酐、ACR、β2微球蛋白升高((58.78±7.77)μmol/L vs(71.75±10.80)μmol/L,(1.01±0.32)μmol/ mg vs(13.76±9.56)μmol/ mg,(1.12±0.15)mg/L vs(2.01±0.53)mg/L), eGFR降低((115.10±12.59)mL·min-1·(1.73 m2)-1 vs(101.09±17.17)mL·min-1·(1.73 m2)-1)。差异有统计学意义(t=7.621、13.591、15.126、-5.120,P均<0.01)。与健康对照组比较,单纯性肥胖组肾损伤指标ACR、β2微球蛋白升高((1.01±0.32)μg/mg vs(4.41±1.16)μg/mg,(1.12±0.15)mg/L vs(1.46±0.26)mg/L),差异均有统计学意义(t=9.732、7.792,P均<0.01)。NAFLD患者ACR与体重指数、腰围、甘油三酯水平、总胆固醇水平、低密度脂蛋白水平、空腹血糖水平、餐后2小时血糖、空腹胰岛素水平、HOMA-IR呈正相关(r=0.554、0.327、0.314、0.353、0.176、0.195、0.552、0.364、0.987,均P<0.05),与高密度脂蛋白呈负相关(r=-0.330, P<0.01)。结论在性别、年龄、血糖、血脂、血压基线相同的情况下,NAFLD与慢性肾脏疾病密切相关。糖脂代谢异常、肥胖和胰岛素抵抗可能是NAFLD患者早期肾损伤的机制。ACR和β2微球蛋白联合检测NAFLD患者早期肾损伤的敏感性高于血清肌酐和eGFR。关键词:非酒精性脂肪肝;肥胖;慢性肾病;早期肾损伤
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Early kidney injury in patients with non-alcoholic fatty liver disease: a cross-sectional study
Objective To investigate early kidney injury in the patients with non-alcoholic fatty liver disease (NAFLD) without hypertension, diabetes and history of kidney diseases, as so to provide evidence for preventing early kidney injury in patients with NAFLD. Methods From December 2014 to January 2016, 169 subjects visiting Sichuan Provincial People′s Hospital were recruited. Among them, 104 cases were in NAFLD group, 31 cases were in simple obesity group (overweight or obesity), and 34 subjects were in the healthy control group. The general data, biochemical indexes, metabolic indexes, biochemical indexes of kidney, and early kidney injury makers, including serum β2-microglobulin, urinary albumin and creatinine ratio (ACR) and estimated glomerular filtration rate (eGFR), were detected. Least significant difference-t test, chi-square test and Spearman correlation analysis were performed for statistical analysis. Results Compared with simple obesity group, alanine aminotransferase (ALT), aspartate aminotransferase (AST), γ-glutamyl transpeptadase (GGT), fasting insulin level, homeostasis model assessment-insulin resistance (HOMA-IR), serum creatinine, ACR and β2 microglobulin were higher in NAFLD group ((21.13±8.14) U/L vs. (66.20±44.34) U/L, (24.80±9.57) U/L vs. (49.78±25.41) U/L, (19.26±7.88) U/L vs. (66.53±56.34) U/L, (7.03±1.52) mU/L vs. (9.55±5.41) mU/L, 1.22±0.38 vs. 2.23±2.01, (62.90±10.01) μmol/L vs. (71.75±10.80) μmol/L, (4.41±1.16) μg/mg vs. (13.76±9.56) μg/mg, (1.46±0.26) mg/L vs. (2.01±0.53) mg/L); however the eGFR was lower (112.46±11.90) mL·min-1·(1.73 m2)-1 vs. (101.09±17.17) mL·min-1·(1.73 m2)-1). The differences were statistically significant (t=9.825, 8.250, 8.288, 4.229, 4.121, 4.007, 9.732, 7.792 and -3.443, all P 0.05). Compared with healthy control group, the renal injury indexes serum creatinine, ACR and β2 microglobulin of NAFLD group were higher((58.78±7.77) μmol/L vs. (71.75±10.80) μmol/L, (1.01±0.32) μg/mg vs. (13.76±9.56) μg/mg, (1.12±0.15) mg/L vs. (2.01±0.53) mg/L), and the eGFR was lower ((115.10±12.59) mL·min-1·(1.73 m2)-1 vs. (101.09±17.17) mL·min-1·(1.73 m2)-1). The differences were statistically significant (t=7.621, 13.591, 15.126 and -5.120, all P<0.01). Compared with healthy control group, the renal injury indexes ACR and β2 microglobulin of simple obesity group were higher ((1.01±0.32) μg/mg vs. (4.41±1.16) μg/mg, (1.12±0.15) mg/L vs. (1.46±0.26) mg/L), and the differences were statistically significant (t=9.732 and 7.792, both P<0.01). ACR of NAFLD patients was positively correlated with body mass index, waist circumference, triglyceride level, total cholesterol level, low density lipoprotein level, fasting blood glucose level, two-hour postprandial blood glucose, fasting insulin level and HOMA-IR (r=0.554, 0.327, 0.314, 0.353, 0.176, 0.195, 0.552, 0.364 and 0.987, all P<0.05), and was negatively correlated with high density lipoprotein (r=-0.330, P<0.01). Conclusions NAFLD is closely related with chronic kidney disease at same baseline of gender, age, blood glucose, blood lipids, and blood pressure. Abnormal metabolism of glycolipids, obesity and insulin resistance may be the mechanisms of early kidney injury in NAFLD patients. Combination of ACR and β2 microglobulin are more sensitive than serum creatinine and eGFR in detecting early renal injury in NAFLD patients. Key words: Nonalcoholic fatty liver disease; Obesity; Chronic kidney disease; Early kidney injury
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
8016
期刊介绍:
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信